"Citing the attack from Macron and unfounded accusations over safety and efficacy, Bell [0] said the company could re-think its philanthropic stance. “There’s a

"Citing the attack from Macron and unfounded accusations over safety and efficacy, Bell [0] said the company could re-think its philanthropic stance. “There’s a point at which AstraZeneca could just say, ‘you’ve got to be joking, we’re going to stop [charging cost price] now because we’re not getting any credit for what we’re doing.’ The share price has gone down, not up. We’re making more vaccines than everybody else. This is a safe and effective vaccine, but nobody seems to care,” he said this week." [0]: Sir John Bell, the Oxford University professor who helped drive the vaccine’s development